Henry Schein Inc
(BSP:H1SI34)
R$
200.2
0 (0%)
Market Cap: 49.92 Bil
Enterprise Value: 74.87 Bil
PE Ratio: 27.98
PB Ratio: 2.44
GF Score: 82/100 Henry Schein Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 09, 2021 / 03:30PM GMT
Release Date Price:
R$213
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst
© -
Great. Okay. So I think we are now live. Thanks so much, everyone, for joining us. We're very pleased to have with us today, Steven Paladino, Executive Vice President, Chief Financial Officer at Henry Schein; Graham Stanley as well, Vice President, Investor Relations and Strategic Financial Project Officer.
My name is Matt Miksic. I cover medical devices here at Credit Suisse. We're very pleased to have Henry Schein participating in our 30th anniversary conference. So thanks so much, gentlemen, for joining us.
Steven Paladino
Henry Schein, Inc. - Executive VP, CFO & Executive Director
Very welcome, Matt.
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst
© -
So I thought it might be relevant to just start with a brief introduction in sort of the environment, how it has been affecting you, how you've been surviving through this past
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot